FORM 4
☐
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
☐ Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
| | |
| 1. Name and Address of Reporting Person * Carlyle Group Inc. | 2. Issuer Name and Ticker or Trading Symbol Medline Inc. [ MDLN ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person | |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Class A Common Stock | 3/4/2026 | C | 8,085,116 (1) | A | (2) | 152,460,797 | I | See footnotes (3)(4)(5)(6) | ||
| Class B Common Stock (7) | 3/4/2026 | J | 8,085,116 (8) | D | (8) | 62,842,239 | I | See footnotes (3)(4)(5)(6) | ||
| Class A Common Stock | 3/5/2026 | C | 1,212,767 (9) | A | (2) | 153,673,564 | I | See footnotes (3)(4)(10)(11) | ||
| Class B Common Stock (7) | 3/5/2026 | J | 1,212,767 (8) | D | (8) | 61,629,472 | I | See footnotes (3)(4)(10)(11) | ||
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
| 1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Common Units of Medline Holdings, LP | (2) | 3/4/2026 | C | 8,085,116 (1) | (2) | (2) | Class A Common Stock | 8,085,116 | $0 | 62,842,239 | I | See footnotes (3)(4)(5)(6) | |||
| Common Units of Medline Holdings, LP | (2) | 3/5/2026 | C | 1,212,767 (9) | (2) | (2) | Class A Common Stock | 1,212,767 | $0 | 61,629,472 | I | See footnotes (3)(4)(10)(11) | |||
| Remarks: Due to the limitations of the electronic filing system, Carlyle Mozart Coinvestment Holdings, L.P., Carlyle Mozart Coinvestment UNLV Holdco, L.P., CP Circle UNLV Holdco, L.P., CPEP GP, LLC, CPEP Circle Holdings L.P., Carlyle Holdings II GP L.L.C., Carlyle Holdings II L.L.C., TC Group Cayman Investment Holdings, L.P., TC Group Cayman Investment Holdings Sub L.P., TC Group VII, L.L.C., TC Group VII, L.P., CP Circle ML-1 Holdco GP, LLC, CP Circle ML-1 Holdco, L.P., CP Circle ML Holdco GP, LLC, CP Circle ML-2 Holdco, L.P., CP Circle ML-3 Holdco, L.P., CP Circle ML-4 Holdco, L.P., CP Circle ML-5 Holdco, L.P., CP Circle ML-6 Holdco, L.P. and CP Circle ML-7 Holdco, L.P. are filing a separate Form 4. |
| Reporting Owners | |||||
| Reporting Owner Name / Address | |||||
| Director | 10% Owner | Officer | Other | ||
| Carlyle Group Inc. C/O THE CARLYLE GROUP INC. 1001 PENNSYLVANIA AVE. NW SUITE 220 S WASHINGTON, DC 20004-2505 | X | ||||
| Carlyle Holdings I GP Inc. C/O THE CARLYLE GROUP INC. 1001 PENNSYLVANIA AVE. NW SUITE 220 S WASHINGTON,, DC 20004-2505 | X | ||||
| Carlyle Holdings I GP Sub L.L.C. C/O THE CARLYLE GROUP INC. 1001 PENNSYLVANIA AVE. NW SUITE 220 S WASHINGTON,, DC 20004-2505 | X | ||||
| Carlyle Holdings I L.P. C/O THE CARLYLE GROUP INC. 1001 PENNSYLVANIA AVE. NW SUITE 220 S WASHINGTON,, DC 20004-2505 | X | ||||
| CG Subsidiary Holdings L.L.C. C/O THE CARLYLE GROUP INC. 1001 PENNSYLVANIA AVE. NW SUITE 220 S WASHINGTON,, DC 20004-2505 | X | ||||
| TC Group, LLC C/O THE CARLYLE GROUP INC. 1001 PENNSYLVANIA AVE. NW SUITE 220 S WASHINGTON,, DC 20004-2505 | X | ||||
| TC Group Sub L.P. C/O THE CARLYLE GROUP INC. 1001 PENNSYLVANIA AVE. NW SUITE 220 S WASHINGTON,, DC 20004-2505 | X | ||||
| TC Group VII S1, L.L.C. C/O THE CARLYLE GROUP INC. 1001 PENNSYLVANIA AVE. NW SUITE 220 S WASHINGTON,, DC 20004-2505 | X | ||||
| TC Group VII S1, L.P. C/O THE CARLYLE GROUP INC. 1001 PENNSYLVANIA AVE. NW SUITE 220 S WASHINGTON,, DC 20004-2505 | X | ||||
| Signatures | ||
| The Carlyle Group Inc., By: /s/ Anne K. Frederick, Corporate Secretary | 3/6/2026 | |
| **Signature of Reporting Person | Date | |
| Carlyle Holdings I GP Inc., By: /s/ Anne K. Frederick, Managing Director | 3/6/2026 | |
| **Signature of Reporting Person | Date | |
| Carlyle Holdings I GP Sub L.L.C., By: Carlyle Holdings I GP Inc., its sole member, By: /s/ Anne K. Frederick, Managing Director | 3/6/2026 | |
| **Signature of Reporting Person | Date | |
| Carlyle Holdings I L.P., By: /s/ Anne K. Frederick, Managing Director | 3/6/2026 | |
| **Signature of Reporting Person | Date | |
| CG Subsidiary Holdings L.L.C., By: /s/ Anne K. Frederick, Managing Director | 3/6/2026 | |
| **Signature of Reporting Person | Date | |
| TC Group, L.L.C., By: /s/ Anne K. Frederick, Managing Director | 3/6/2026 | |
| **Signature of Reporting Person | Date | |
| TC Group Sub L.P., By: TC Group, L.L.C., its general partner, By: /s/ Anne K. Frederick, Managing Director | 3/6/2026 | |
| **Signature of Reporting Person | Date | |
| TC Group VII S1, L.L.C., By: /s/ Jeremy Anderson, Vice President | 3/6/2026 | |
| **Signature of Reporting Person | Date | |
| TC Group VII S1, L.P., By: TC Group VII S1, L.L.C., its general partner, By: /s/ Jeremy Anderson, Vice President | 3/6/2026 | |
| **Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | |